Spring direct naar de hoofdnavigatie of de inhoud

New on Kluwer Patent Blog: Bayer Intellectual Property GmbH vs. Ceva Santé Animale SA, Nederland

Bayer was not granted an injunction in preliminary proceedings because the Court found that there was a serious chance that Bayer’s patent would be held invalid.

The fact that the patent had survived opposition before the EPO was of no influence since new, closer prior art had subsequently been found.

Read the complete article by Bart van Wezenbeek on Kluwer IP Law.

Also see these experts

Frits Michiels

Frits Michiels

  • European and Dutch Patent Attorney
  • Valuation specialist
  • Partner
Frits Schut

Frits Schut

  • European and Dutch Patent Attorney
  • Partner
More experts